Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRACLE-T2D: Montelukast for Renal, Cardiovascular and Eye Health in Type 2 Diabetes
NCT07685886Phase 4Not yet recruiting
- Sponsor
- University of Colorado Denver
- Start
- Sep 2026
- Primary completion
- Jun 2031
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast in type 2 diabetes mellitus (T2DM), diabetic kidney disease (DKD), diabetic retinopathy (DR), vascular disease, sponsored by University of Colorado Denver. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
montelukast
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic kidney disease (DKD)diabetic retinopathy (DR)vascular disease
Beyond the preview
Go deeper on NCT07685886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07685886.